Disposition of the second messenger nitric oxide (NO) in mammalian tissues occurs through multiple pathways including dioxygenation by erythrocyte hemoglobin and red muscle myoglobin. Metabolism by a putative NO dioxygenase activity in non-striated tissues has also been postulated, but the exact nature of this activity is unknown. In the present study, we tested the hypothesis that cytoglobin, a newly discovered hexacoordinated globin, participates in cell-mediated NO consumption. Stable expression of small hairpin RNA targeting cytoglobin in fibroblasts resulted in decreased NO consumption and intracellular nitrate production. These cells were more sensitive to NO-induced inhibition of cell respiration and proliferation, which could be restored by re-expression of human cytoglobin. We also demonstrated cytoglobin expression in adventitial fibroblasts as well as vascular smooth muscle cells from various species including human and found that cytoglobin was expressed in the adventitia and media of intact rat aorta. These results indicate that cytoglobin contributes to cell-mediated NO dioxygenation and represents an important NO sink in the vascular wall.
Nitric oxide (NO)2 plays a central role in the vasculature and regulates oxygen supply by relaxing smooth muscle and inhibiting mitochondrial respiration. NO is produced by nitric-oxide synthase and through mobilization of storage pools such as nitrite. Less is known on the mechanism of NO inactivation and removal in the vasculature, although it would be surprising that blood vessels rely on nonspecific chemical reactions to control its disposition.Blood removes NO through reaction with excess oxyhemoglobin in erythrocytes, but diffusional barriers such as the red blood cell-free layer near the vessel wall allow autocrine NO to occur in significant amounts in the vascular wall (1, 2). In striated muscles, oxymyoglobin is an NO scavenger, and studies using transgenic mice lacking myoglobin have demonstrated a role for oxymyoglobin in attenuating NO-mediated cardiac dysfunction (3, 4). In contrast, NO inactivation in non-striated tissues is poorly understood, and examination of NO consumption in various cells suggests mechanisms that differ in NO saturation, oxygen and cyanide sensitivity, and product formation (5-8). Specific pathways include increased partition of NO in cell membranes (7) and consumption of NO by cytochrome c oxidase (9 -11), NADPH oxidase (12), 15-lipoxygenase (13), prostaglandin-H synthase (14), and myeloperoxidase (15).Many of the above mechanisms implicate metalloproteins as modulators of NO bioavailability among which the role of oxyglobins such as oxyhemoglobin and oxymyoglobin have been already highlighted (16). One of the primary mechanisms is the dioxygenation of NO to form nitrate and the ferric (Fe(III)) form of the protein. The recent discovery of two new mammalian globins, cytoglobin and neuroglobin, would suggest that the reactions of NO with globins are not limited to red blood cells and striated muscles but could extend to other ...